Add like
Add dislike
Add to saved papers

Epidemiological and clinical aspects of dermatophytoses in Eastern Slovakia: a retrospective three-year study.

OBJECTIVE: A three-year retrospective study of fungi isolated from samples of patients with suspected fungal skin infections in Eastern Slovakia is presented.

METHODS: A total of 11,989 samples were collected and investigated with direct microscopic examination using 20% KOH and cultivated in Sabouraud and Mycosel medium. Identification was based on macroscopic and microscopic characteristics.

RESULTS: Of the total samples, 61.76% (7,405/11,989) were completely negative and 38.24% positive (4,584/11,989). Dermatophytes accounted for 45.88% of isolates (2,103/4,584), yeasts for 26.79% (1,228/4,584), non-dermatophytes for 15.29% (701/4,584), and Malassezia sp. for 12.4% (552/4,584). Trichophyton rubrum was the most prevalent causative agent (79.08%) implicated in fungal skin infections, followed by Trichophyton interdigitale (10.60%). Less frequent isolates included Trichophyton tonsurans (5.13%), and Trichophyton mentagrophytes (3.14%). Other dermatophytes (Microsporum audouinii, Microsporum gypseum, Microsporum canis, Trichophyton violaceum, Trichophyton verrucosum, and Epidermophyton floccosum) were very rarely identified (each in less than 1% of all samples). The main clinical form of dermatophytosis in the sample was tinea unguium (42.61%), followed by tinea pedis (30.86%), tinea inguinalis (11.65%), tinea corporis (8.04%), and tinea manus (4.76%). Tinea capitis et faciei (2.08%) was more common among children and adolescents.

CONCLUSION: The assessment of data has showed the predominance of tinea unguium among adult patients, tinea capitis et faciei among children, and the prevalent aetiological role of Trichophyton rubrum in fungal skin infections; findings that are in agreement with recent European studies.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app